148 related articles for article (PubMed ID: 32185247)
1. Advances in Systemic Lupus Erythematosus (SLE): A case for optimism.
Fanouriakis A; Boumpas DT
Mediterr J Rheumatol; 2017 Mar; 28(1):1-3. PubMed ID: 32185247
[No Abstract] [Full Text] [Related]
2. Risk prediction models for incident systemic lupus erythematosus among women in the Nurses' health study cohorts using genetics, family history, and lifestyle and environmental factors.
Cui J; Malspeis S; Choi MY; Lu B; Sparks JA; Yoshida K; Costenbader KH
Semin Arthritis Rheum; 2023 Feb; 58():152143. PubMed ID: 36481507
[TBL] [Abstract][Full Text] [Related]
3. The differential panorama of clinical features of lupus erythematosus patients with different onset ages: a cross-sectional multicenter study from China.
Yu Y; Jin H; Zhou S; Zhao M; Wu H; Long H; Fu S; Wu R; Yin H; Liao J; Luo S; Liu Y; Zhang Q; Zhang P; Tan Y; Huang X; Li F; Lin G; Lu Q
Clin Rheumatol; 2023 Sep; 42(9):2353-2367. PubMed ID: 37311918
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
5. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.
Yildirim Cetin G; Sayar H; Ozkan F; Kurtulus S; Kesici F; Sayarlioglu M
Lupus; 2013 Jul; 22(8):839-46. PubMed ID: 23761100
[TBL] [Abstract][Full Text] [Related]
6. The involvement of galectin-3 in skin injury in systemic lupus erythematosus patients.
Shi Z; Meng Z; Han Y; Cao C; Tan G; Wang L
Lupus; 2018 Apr; 27(4):621-627. PubMed ID: 29058991
[TBL] [Abstract][Full Text] [Related]
7. Treatment of systemic lupus erythematosus in 2006.
Sibilia J
Joint Bone Spine; 2006 Dec; 73(6):591-8. PubMed ID: 17110151
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in conventional and biologic therapy for systemic lupus erythematosus.
Wofsy D
Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii66-8. PubMed ID: 23253930
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the treatment of systemic lupus erythematosus with belimumab in children.
Deng WP
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1069-1074. PubMed ID: 34719425
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of microRNA-762 suppresses the expression of GIPC3 in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus.
Yang J; Li C; Chi S; Wei H; Du W; Hu Q
Immun Inflamm Dis; 2022 Nov; 10(11):e719. PubMed ID: 36301034
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
[TBL] [Abstract][Full Text] [Related]
12. The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus.
Flynn A; Gilhooley E; O'Shea F; Wynne B
Clin Rheumatol; 2018 Mar; 37(3):817-818. PubMed ID: 29392510
[TBL] [Abstract][Full Text] [Related]
13. White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus.
Cannerfelt B; Nystedt J; Jönsen A; Lätt J; van Westen D; Lilja A; Bengtsson A; Nilsson P; Mårtensson J; Sundgren PC
Lupus; 2018 Jun; 27(7):1140-1149. PubMed ID: 29523054
[TBL] [Abstract][Full Text] [Related]
14. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
Tiao J; Feng R; Carr K; Okawa J; Werth VP
J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
[TBL] [Abstract][Full Text] [Related]
15. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
Zhou W; Wu H; Zhao M; Lu Q
Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
[TBL] [Abstract][Full Text] [Related]
16. B cell depletion and inhibition in systemic lupus erythematosus.
Krustev E; Clarke AE; Barber MRW
Expert Rev Clin Immunol; 2023 Jan; 19(1):55-70. PubMed ID: 36342225
[TBL] [Abstract][Full Text] [Related]
17. Low apolipoprotein M serum levels correlate with Systemic lupus erythematosus disease activity and apolipoprotein M gene polymorphisms with Lupus.
Du W; Shen T; Li H; Liu Y; He L; Tan L; Hu M; Ren Y
Lipids Health Dis; 2017 May; 16(1):88. PubMed ID: 28476116
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptive therapy and systemic lupus erythematosus.
Travers RL; Hughes GR
J Rheumatol; 1978; 5(4):448-51. PubMed ID: 310887
[TBL] [Abstract][Full Text] [Related]
20. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
Cho YM; Furie R
Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
